Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Johnson & Johnson buy Saftman

Start price
€142.86
08.07.21 / 50%
Target price
-
08.07.22
Performance (%)
22.71%
End price
€175.30
08.07.22
Summary
This prediction ended on 08.07.22 with a price of €175.30. The prediction had a final performance of 22.71%. Dividends of €3.84 are taken into consideration when calculating the performance. Saftman has 50% into this prediction

Johnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.

Performance without dividends (%)
Name 1w 1m 1y
Johnson & Johnson 2.160% 2.160% 4.744%
iShares Core DAX® 1.883% 5.122% 21.667%
iShares Nasdaq 100 0.125% 2.574% 45.951%
iShares Nikkei 225® -0.201% 4.341% 28.806%
iShares S&P 500 0.728% 4.141% 34.630%

Comments by Saftman for this prediction

In the thread Johnson & Johnson diskutieren

Saftman hat das Wertpapier Johnson & Johnson in seinem Wikifolio Langfristige Aufwärtstrends gekauft.

In the thread Trading Johnson & Johnson
Prediction Buy
Perf. (%) 22.71%
Target price
Change
Ends at 08.07.22

Die von Saftman gewählte maximale Laufzeit wurde überschritten